Trademarkia Logo

Canada

C$
NAXEPRY
FORMALIZED

on 19 Mar 2025

Last Applicant/ Owned by

AMPHASTAR PHARMACEUTICALS, INC.

11570 Sixth StreetRancho Cucamonga CA 91730

US

Serial Number

2387072 filed on 8th Jan 2025

Correspondent Address

MICHELLE L. WASSENAAR

(METHOD LAW PROFESSIONAL CORPORATION)4211 Yonge StreetSuite 310Toronto

ONTARIO

CA

M2P2A9

NAXEPRY

Trademark usage description

nasal spray preparations; nasal sprays for medical purposes; nasal spray preparations for use in treating type 1 anaphylaxis reactions; pharmaceutical Read More

Classification Information


Class [005]
Nasal spray preparations; nasal sprays for medical purposes; nasal spray preparations for use in treating Type 1 anaphylaxis reactions; pharmaceutical formulations for use in treating Type 1 anaphylaxis reactions.


Classification kind code

12

Class [016]
Printed matter, namely, brochures, leaflets, and manuals in the field of pharmaceuticals, pharmaceutical research, and healthcare.


Classification kind code

12

Class [044]
Providing medical information via a website; providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals.


Classification kind code

12

Mark Details


Serial Number

2387072

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 27th Mar 2025
Agent Changed
Submitted for opposition 257
on 20th Mar 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Mar 2025
Created
Submitted for opposition 31
on 19th Mar 2025
Formalized
Submitted for opposition 30
on 8th Jan 2025
Filed
Submitted for opposition 228
on 8th Jan 2025
International Registration